As noted in our very first post about clinical trials for Fragile X Syndrome: “The intention here is to take a slightly different perspective. First, it is interesting to note that in many articles describing the results of clinical trials, the repeated positive results of drug tests in “Fragile X” (FX) animal models are cited […]